, Volume 33, Issue 2, pp 131–138

Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on fatty acid absorption, incorporation into serum phospholipids and postprandial triglyceridemia

  • John-Bjarne Hansen
  • Sameline Grimsgaard
  • Hugo Nilsen
  • Arne Nordøy
  • Kaare H. Bønaa


Fourteen healthy volunteers were randomly allocated to receive 4 g highly purified ethyl esters of eicosapentaenoic acid (EPA) (95% pure, n=7) or docosahexaenoic acid (DHA) (90% pure, n=7) daily for 5 wk in supplement to their ordinary diet. The n−3 fatty acids were given with a standard high-fat meal at the beginning and the end of the supplementation period. EPA and DHA induced a similar incorporation into chylomicrons which peaked 6 h after the meal. The relative uptake of EPA and DHA from the meal was >90% compared with the uptake of oleic acid. During absorption, there was no significant elongation or retroconversion of EPA or DHA in total chylomicron fatty acids. The concentration of EPA decreased by 13% and DHA by 62% (P<0.001) between 6 and 8 h after the meal. During the 5-wk supplementation period, EPA showed a more rapid and comprehensive increase in serum phospholipids than did DHA. DHA was retroconverted to EPA, whereas EPA was elongated to docosapentaenoic acid (DPA). The postprandial triglyceridemia was suppressed by 19 and 49% after prolonged intake of EPA and DHA, respectively, indicating that prolonged intake of DHA is equivalent to or even more efficient than that of EPA in lowering postprandial triglyceridemia. This study indicates that there are metabolic differences between EPA and DHA which may have implications for the use of n−3 fatty acids in preventive and clinical medicine.





docosahexaenoic acid


docosapentaenoic acid


ethyl esters


ereosapentaenoic acid


fatty acid


high density lipoproteins


linoleic acid


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Schmidt, E.B., and Dyerberg, J. (1994) Omega-3 Fatty Acids: Current Status in Cardiovascular Medicine, Drugs 47, 405–424.PubMedCrossRefGoogle Scholar
  2. 2.
    Hansen, J.B., Lyngmo, V., Svensson, B., and Nordøy, A. (1993) Inhibition of Exercise-Induced Shortening of Bleeding Time by Fish Oil in Familial Hypercholesterolemia (Type lla), Arterioscler. Thromb. 13, 98–104.PubMedGoogle Scholar
  3. 3.
    Zilversmit, D.B. (1979) Atherogenesis: A Postprandial Phenomenon, Circulation 60, 473–485.PubMedGoogle Scholar
  4. 4.
    Barrit, D.W. (1956) Alimentary Lipaemia in Men with Coronary Artery Disease and in Controls, Br. Med. J. 2, 640–644.CrossRefGoogle Scholar
  5. 5.
    Brown, D.F., Heslin, A.S., and Doyle, J.T. (1961) Postprandial Lipemia in Health and in Ischemic Heart Disease: A Comparison of Three Indexes of Fat Absorption and Removal and Their Modification by Systemic Heparin Administration, N. Engl. J. Med. 264, 733–737.CrossRefGoogle Scholar
  6. 6.
    Patsch, J.R., Miesenböck, G., Hopferwieser, T., Mühlberger, V., Knapp, E., Dunn, J.K., Gotto, A.M. Jr., and Patsch, W. (1992) Relation of Triglyceride Metabolism and Coronary Artery Disease: Studies in the Postprandial State, Arterioscler. Thromb. 12, 1336–1345.PubMedGoogle Scholar
  7. 7.
    Weintraub, M.S., Zechner, R., Brown, A., Eisenberg, S., and Breslow, J.L. (1988) Dietary Polyunsaturated Fats of the n−6 and n−3 Series Reduce Postprandial Lipoprotein Levels, J. Clin. Invest. 82, 1884–1893.PubMedGoogle Scholar
  8. 8.
    Harris, W.S., Connor, W.E., Alam, N., and Illingworth, D.R. (1988) Reduction of Postprandial Triglyceridemia in Humans by Dietary n−3 Fatty Acids, J. Lipid. Res. 29, 1451–1460.PubMedGoogle Scholar
  9. 9.
    Harris, W.S., and Muzio, F. (1993) Fish Oil Reduces Postprandial Triglyceride Concentrations Without Accelerating Lipid-Emulsion Removal Rates, Am. J. Clin. Nutr. 58, 68–74.PubMedGoogle Scholar
  10. 10.
    Willumsen, N., Hexeberg, S., Skorve, J., Lundquist, M., and Berge, R.K. (1993) Docosahexaenoic Acid Shows No Triglyceride-Lowering Effects But Increases the Peroxisomal Fatty Oxidation in Liver of Rats, J. Lipid. Res. 34, 13–22.PubMedGoogle Scholar
  11. 11.
    Grimsgaard, S., Bønaa, K.H., Hansen, J.B., and Nordøy, A. (1997) Highly Purified Eicosapentaenoic Acid and Docosa-hexaenoic Acid in Humans Have Similar Triacylglycerol Lowering Effects, But Divergent Effects on Plasma Fatty Acids, Am. J. Clin. Nutr. 66, 649–659.PubMedGoogle Scholar
  12. 12.
    Bønaa, K.H., Bjerve, K.S., and Nordøy, A. (1992) Docosahexaenoic and Eicosapentaenoic Acids in Plasma Phospholipids Are Divergently Associated with High Density Lipoprotein in Humans, Arterioscler. Thromb. 12, 675–681.PubMedGoogle Scholar
  13. 13.
    El Boustani, S., Coletta, C., Monnier, L., Descomps, B., Crastes de Paulet, A., and Mendy, F. (1987) Enteral Absorption in Man of Eicosapentaenoic Acid in Different Chemical Forms, Lipids 22, 711–714.PubMedGoogle Scholar
  14. 14.
    Lawson, L.D., and Hughes, B.G. (1988) Human Absorption of Fish Oil Fatty Acids as Triglycerides, Free Acids or Ethyl Esters, Biochem. Biophys. Res. Commun. 152, 328–335.PubMedCrossRefGoogle Scholar
  15. 15.
    Nordøy, A., Barstad, L., Connor, W.E., And Hatcher, L. (1991) Absorption of the n−3 Eicosapentaenoic and Docosahexaenoic Acids as Ethyl Esters and Triglycerides by Humans, Am. J. Clin. Nutr. 53, 1185–1190.PubMedGoogle Scholar
  16. 16.
    Hansen, J.B., Olsen, J.O., Wilsgård, L., Lyngmo, V., and Svensson, B. (1993) Comparative Effects of Prolonged Intake of Highly Purified Fish Oils as Ethyl Ester or Triglyceride on Lipids, Haemostasis and Platelet Function in Normolipemic Men, Eur. J. Clin. Nutr. 47, 497–507.PubMedGoogle Scholar
  17. 17.
    Krokan, H.E., Bjerve, K.S., and Mørk, E. (1993) The Enteral Bioavailability of Eicosapentaenoic and Docosahexaenoic Acid Is as Good as from Ethyl Esters as from Glyceryl Esters in Spite of Lower Hydrolytic Rates by Pancreatic Lipase in vitro, Biochim. Biophys. Acta. 1168, 59–67.PubMedGoogle Scholar
  18. 18.
    Aviram, M., Brox, J., and Nordøy, A. (1986) Effects of Postprandial Plasma and Chylomicrons on Endothelial Cells, Acta. Med. Scand. 219, 341–348.PubMedCrossRefGoogle Scholar
  19. 19.
    Folch, J., Lees M., and Stanley, S. (1957) A Simple Method for the Isolation and Purification of Total Lipids from Animal Tissue, J. Biol. Chem. 226, 497–509.PubMedGoogle Scholar
  20. 20.
    Kaluzny, M.A., Duncan, L.A., Merritt, M.V., and Epps, D.E. (1985) Rapid Separation of Lipid Classes in High Yield and Purity Using Bonded Phase Columns, J. Lipid. Res. 26, 135–140.PubMedGoogle Scholar
  21. 21.
    Sas Institute, Inc: SAS/STAT guide for personal computers, version 6. Edn. Cary NC, SAS Institute 1987/1990.Google Scholar
  22. 22.
    Heimermann, W.R., Hohman, R.T., Gordon, D.T., Korvalyskyn, D.E., and Jensen, R.G. (1973) Effect of Double Bond Position in Octadecenoates upon Hydrolysis of Pancreatic Lipase, Lipids 8, 45–47.PubMedGoogle Scholar
  23. 23.
    Yang, L.Y., Kukis, A., and Myker, J.J. (1990) Lipolysis of Menhaden Oil Triacyl Glycerols in vitro: A Reexamination, J. Lipid. Res. 31, 137–147.PubMedGoogle Scholar
  24. 24.
    Neuringer, M., Anderson, G.J., and Connor, W.E. (1988) The Essentiality of n−3 Fatty Acids for the Development and Function of the Retina and Brain, Annu. Rev. Nutr. 8, 517–541.PubMedCrossRefGoogle Scholar
  25. 25.
    Anderson, G.J., Tso, P.S., and Connor, W.E. (1994) Incorporation of Chylomicron Fatty Acids into the Developing Rat Brain, J. Clin. Invest. 93, 2764–2767.PubMedCrossRefGoogle Scholar
  26. 26.
    Terano, T., Hirai, A., Hamazaki, T., Kobayashi, S., Fujita, T., Tamura, Y., and Kumagai, A. (1983) Effect of Oral Administration of Highly Purified Eicosapentaenoic Acid on Platelet Function, Blood Viscosity, and Red Cell Deformability in Healthy Human Subjects, Atherosclerosis 46, 321–331.PubMedCrossRefGoogle Scholar
  27. 27.
    von Schacky, C., and Weber, P.C. (1985) Metabolism and Effects on Platelet Function of the Purified Eicosapentaenoic and Docosahexaenoic Acids in Humans, J. Clin. Invest. 76, 2446–2450.Google Scholar
  28. 28.
    Schlenk, H., Sand, D.M., and Gellerman, J.L. (1969) Retroconversion of Docosahexaenoic Acid in the Rat, Biochim. Biophys. Acta. 187, 201–207.PubMedGoogle Scholar
  29. 29.
    Stoffel, W., Ecker, W., Assad, H., and Sprecher, H. (1970) Enzymatic Studies on the Mechanism of the Retroconversion of C22-Polyenoic Fatty Acids to Their C20 Homologues, Z. Physiol. Chem. 351, 1545–1554.Google Scholar
  30. 30.
    Connor, W.E., DeFrancesco, C.A., and Connor, S.L. (1993) n-3 Fatty Acids from Fish Oil. Effects on Plasma Lipoproteins and Hypertriglyceridemic Patients, Ann. NY. Acad. Sci. 683, 16–34.PubMedGoogle Scholar
  31. 31.
    Ranheim, T., Gedde-Dahl, A., Rustan, A.C., and Drevon, C.A. (1992) Influence of Eicosapentaenoic Acid (20:5n−3) on Secretion of Lipoproteins in CaCo-2 Cells, J. Lipid. Res. 33, 1281–1293.PubMedGoogle Scholar
  32. 32.
    Rustan, A.C., Nossen, J.O., Christiansen, E.N., and Drevon, C.A. (1988) Eicosapentaenoic Acid Reduces Hepatic Synthesis and Secretion of Triacylglycerol by Decreasing the Activity of Acyl-Coenzyme A:1,2-Diacylglycerol Acyltransferase, J. Lipid Res. 29, 1417–1426.PubMedGoogle Scholar
  33. 33.
    Lang, C.A., and Davis, R.A. (1990) Fish Oil Fatty Acids Impair VLDL Assembly and/or Secretion by Cultured Rat Hepatocytes, J. Lipid. Res. 31, 2079–2086.PubMedGoogle Scholar
  34. 34.
    Wong, S.H., Nestel, P.J., Trimble, R.P., Storer, G.B., Illman, R.J., and Topping, D.L. (1984) The Adaptive Effects of Dietary Fish and Safflower Oil on Lipid and Lipoprotein Metabolism in Perfused Rat Liver, Biochim. Biophys. Acta. 792, 103–109.PubMedGoogle Scholar
  35. 35.
    Wong, S., Fisher, E.A., and Marsh, J.B. (1989) Effects of Eicosapentaenoic and Docosahexaenoic Acids on Apoprotein B mRNA and Secretion of Very Low Density Lipoproteins in HepG2 Cells, Arteriosclerosis 9, 836–841.PubMedGoogle Scholar
  36. 36.
    Martin, L.J., Reaidi, G.B., Gavino, G.R., and Gavino, V.C. (1991) Effect of 4, 7, 10, 13, 16, 19-Docosahexaenoic Acid on Triglyceride Accumulation and Secretion in Rat Hepatocytes in Culture, Lipids 26, 374–380.PubMedGoogle Scholar
  37. 37.
    Simons, L.A., Dwyer, T., Simons, J., Bernstein, L., Mock, P., Poonia, N.S., Balasubramaniam, S., Baron, D., Branson, J., Morgan, J., and Roy, P. (1987) Chylomicrons and Chylomicron Remnants in Coronary Artery Disease: A Case-Control Study, Atherosclerosis 65, 181–189.PubMedCrossRefGoogle Scholar

Copyright information

© AOCS Press 1998

Authors and Affiliations

  • John-Bjarne Hansen
    • 3
  • Sameline Grimsgaard
    • 1
  • Hugo Nilsen
    • 2
  • Arne Nordøy
    • 3
  • Kaare H. Bønaa
    • 1
  1. 1.Institute of Community MedicineUniversity of TromsøTromsøNorway
  2. 2.Department of Clinical NutritionTromsø University HospitalTromsøNorway
  3. 3.Institute of Clinical Medicine, Department of MedicineUniversity of TromsøTromsøNorway

Personalised recommendations